Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations

References

• May SM, Li JTC. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015;36(1):4–10. doi:10.2500/aap.2015.36.3812
   PubMed Web of Science ®Google Scholar
• Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a Cross-Sectional Study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12(1):26. doi:10.1186/1471-2466-12-26
   PubMed Web of Science ®Google Scholar
• Franssen FME, Rochester CL. Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter? Eur Respir Rev. 2014;23(131):131. doi:10.1183/09059180.00007613
   PubMedGoogle Scholar
• Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235–245. doi:10.2147/CEOR.S34321
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Report; 2020. Available from: https://goldcopd.org/. Accessed August, 2020.
   Google Scholar
• Pavord ID, Jones PW, Burgel P-R, Rabe KF. Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11(Spec Iss):21–30. doi:10.2147/COPD.S85978
   PubMedGoogle Scholar
• Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Noyes K, Zhao J, et al. Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary disease in the nationwide readmissions database. Ann Am Thorac Soc. 2018;15(7):837–845. doi:10.1513/AnnalsATS.201712-913OC
   PubMed Web of Science ®Google Scholar
• National Committee for Quality Assurance. Pharmacotherapy management of COPD exacerbation. Available from http://passporthealthplan.com/wp-content/uploads/2015/10/PCE-Pharmacotherapy-Management-of-COPD-Exacerbation.pdf. Accessed August, 2020.
   Google Scholar
• Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963. doi:10.1136/thoraxjnl-2011-201518
   PubMed Web of Science ®Google Scholar
• Diette GB, Dalal AA, D’Souza AO, Lunacsek OE, Nagar SP. Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States. Int J Chron Obstruct Pulmon Dis. 2015;10:415–422. doi:10.2147/COPD.S75034
   PubMed Web of Science ®Google Scholar
• Make B, Dutro MP, Paulose-Ram R, Marton JP, Mapel DW. Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients. Int J Chron Obstruct Pulmon Dis. 2012;7:1–9. doi:10.2147/COPD.S27032
   PubMed Web of Science ®Google Scholar
• Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006;130(6):1844–1850. doi:10.1378/chest.130.6.1844
   PubMed Web of Science ®Google Scholar
• Chan KP, Ko FW, Chan HS, et al. Adherence to a COPD treatment guideline among patients in Hong Kong. Int J Chron Obstruct Pulmon Dis. 2017;12:3371–3379. doi:10.2147/COPD.S147070
   PubMed Web of Science ®Google Scholar
• Genao L, Durheim MT, Mi X, Todd JL, Whitson HE, Curtis LH. Early and long-term outcomes of older adults after acute care encounters for chronic obstructive pulmonary disease exacerbation. Ann Am Thorac Soc. 2015;12(12):1805–1812. doi:10.1513/AnnalsATS.201504-250OC
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Tsugawa Y, Tsai C-L, Brown DF, Camargo CA Jr. Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease. Respir Res. 2014;15(1):40. doi:10.1186/1465-9921-15-40
   PubMed Web of Science ®Google Scholar
• Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB, Respiratory Effectiveness G. Predicting frequent COPD exacerbations using primary care data. Int J Chron Obstruct Pulmon Dis. 2015;10:2439–2450. doi:10.2147/COPD.S94259
   PubMed Web of Science ®Google Scholar
• Kumbhare SD, Beiko T, Wilcox SR, Strange C. Characteristics of COPD patients using United States emergency care or hospitalization. Chronic Obstr Pulm Dis. 2016;3(2):539–548. doi:10.15326/jcopdf.3.2.2015.0155
   PubMedGoogle Scholar
• Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012;9(2):131–141. doi:10.3109/15412555.2011.650239
   PubMedGoogle Scholar
• Rezaee ME, Ward CE, Nuanez B, Rezaee DA, Ditkoff J, Halalau A. Examining 30-day COPD readmissions through the emergency department. Int J Chron Obstruct Pulmon Dis. 2017;13:109–120. doi:10.2147/COPD.S147796
   PubMed Web of Science ®Google Scholar
• Tran M, Xiang P, Rascati KL, et al. Predictors of appropriate pharmacotherapy management of COPD exacerbations and impact on 6-month readmission. J Manag Care Spec Pharm. 2016;22(10):1186–1193. doi:10.18553/jmcp.2016.22.10.1186
   PubMed Web of Science ®Google Scholar
• Amin AN, Bollu V, Stensland MD, Netzer L, Ganapathy V. Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2018;75(6):359–366. doi:10.2146/ajhp160979
   PubMed Web of Science ®Google Scholar
• Price L, Billups SJ, Rice MA, Hartsfield C. Investigation of barriers to clinical practice guideline-recommended pharmacotherapy in the treatment of COPD. Pharm Pract (Granada). 2007;5(2):74–77. doi:10.4321/s1886-36552007000200004
   PubMedGoogle Scholar
• Lipson DA, Barnacle H, Birk R, et al. FULFIL Trial: once-daily triple therapy for patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196(4):438–446. doi:10.1164/rccm.201703-0449OC
   PubMed Web of Science ®Google Scholar
• Lipson DA, Barnhart F, Brealey N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378(18):1671–1680. doi:10.1056/NEJMoa1713901
   PubMed Web of Science ®Google Scholar
• Bogart M, Glassberg MB, Reinsch T, Stanford RH. Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care setting. Respir Med. 2018;145:138–144. doi:10.1016/j.rmed.2018.10.01
   PubMed Web of Science ®Google Scholar
• Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;383(1):35–48. doi:10.1056/NEJMoa1916046
   PubMed Web of Science ®Google Scholar